Concepedia

Birthe Lund

BL

Statistics

Publications

32

Citations

2.5K

H-Index

21

Active since

1969

Affiliations

Rigshospitalet(Current)

Bispebjerg Hospital

Herlev Hospital

Utrecht University

European Organisation for Research and Treatment of Cancer

Birthe Lund is an author at Rigshospitalet specializing in medicine, oncology, and ovarian cancer.

ORCID

Top concepts

Publications per year

1969–2001

32

Publications

32

Exploratory Phase III Study of Paclitaxel and Cisplatin Versus Paclitaxel and Carboplatin in Advanced Ovarian Cancer

Jan P. Neijt, Svend Aage Engelholm, Malgorzata Tuxen et al. · Journal of Clinical Oncology · 2000 · 441 citations

Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer: a phase II study.

Heather Anderson, Birthe Lund, Flemming W. Bach et al. · Journal of Clinical Oncology · 1994 · 376 citations

Phase II Study of Gemcitabine (2',2'-Difluorodeoxycytidine) in Previously Treated Ovarian Cancer Patients

Birthe Lund, Ole Hansen, Karen Theilade et al. · JNCI Journal of the National Cancer Institute · 1994 · 346 citations

Advanced epithelial ovarian cancer: 1993 consensus statements

Darlene Allen, J. Baak, D Belpomme et al. · Annals of Oncology · 1993 · 185 citations · Full text

, , +4

Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia

Geisler Ch, JK Larsen, NE Hansen et al. · Blood · 1991 · 183 citations · Full text

1–5 of 32